It is fast becoming the defining feature of this Government. It’s a nasty habit, and a deeply dangerous one that could come back to haunt them.Read More

You might also be interested in reading BioCardia outlines regulatory milestones and targets FDA and PMDA submissions for CardiAMP and Helix in Q4 2025.